gilteritinib,venetoclax 
astellas pharmaceuticals,roche,abbvie
['leusm', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'gilteritinib']
#eha2022 | daver discussed how to target each molecular subgroup, beginning with flt3 mutated #aml, and how a combination of gilteritinib and ven improves transition to allo-hsct #leusm 
The AML Hub is an evidence-based online resource on Acute Myeloid Leukemia (AML), for academic researchers and treating clinicians. #leusm